Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs INVH✓SelectedUSD · INVHGSK vs INVH performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs INVH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.9%
INVH return
+68.9%
Excess return
+23.0%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioINVHExcessAlpha
1D-0.1%+0.5%-0.7%-0.3%
7D-5.3%-2.3%-3.0%-4.7%
30D-3.7%-2.2%-1.5%-3.0%
3M-7.3%-12.4%+5.1%-3.5%
6M-4.2%-8.1%+3.9%-1.8%
YTD+0.9%-2.4%+3.3%+1.3%
1Y+7.3%-1.9%+9.2%+7.6%
3Y+52.7%-12.3%+65.1%+56.9%
5Y+40.1%-24.1%+64.2%+48.0%
All+91.9%+68.9%+23.0%+61.4%

Cumulative growth

Daily Returns

Daily percentage return beside INVH.

Daily Out/Under-Performance

Portfolio return minus INVH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × INVH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded INVH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling